As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient ...

Generally, each drug made up of two components that are API and excipients, having curative activity. APIs are often known as bulk pharmaceuticals and most of all APIs are in powder form.New York ...

BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to the new report published by Global Market Estimates, the Pantoprazole API Market will rise at a CAGR assessment of 3.2% during ...

To learn more about LGM Pharma’s unique integrated suite of API sourcing and drug product CDMO services, visit LGM Pharma’s Booth (#1615) at CPhI North America, May 17-19, 2022, Philadelphia, PA.

The global Active Pharmaceutical Ingredients (API) Market is valued at USD 155.2 Billion in 2023 and is projected to reach a value of USD 314.24 Billion by 2032 at a CAGR (Compound Annual Growth Rate) ...

Pharmaceutical companies are increasingly focusing on acquisitions in the Active Pharmaceutical Ingredients (API) and formulation space to consolidate market share and diversify portfolios, global ...

Recently, news reports said that pharma giant Lupin might be looking to spin off its active pharmaceutical ingredient (API) vertical. Whether it would be listed as a separate entity or sold off is ...

C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug.

As per the pre-feasibility report submitted to the ministry of environment and forests (MoEF), Aurobindo Pharma has stated that it proposes to expand the API manufacturing capacity from 583.31 TPM ...